| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/17/2009 | US7491410 Food grade transglutaminase inhibitor and uses thereof |
| 02/17/2009 | US7491401 Lawsonia intracellularis vaccine |
| 02/17/2009 | CA2445189C Carboline derivatives as pdev inhibitors |
| 02/17/2009 | CA2400217C Pteridine compounds for the treatment of psoriasis |
| 02/17/2009 | CA2348380C Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level |
| 02/17/2009 | CA2217054C Compositions and methods for inhibiting thrombogenesis |
| 02/16/2009 | CA2696400A1 Hemostatic agent composition and method of delivery |
| 02/15/2009 | CA2628900A1 Monoclonal antibodies against .beta.3 integrins |
| 02/12/2009 | WO2009018640A1 Use of platelet aggregation and coagulation inhibitors isolated from bauhinia sp. |
| 02/12/2009 | WO2008137753A3 Intravenous and oral dosing of a direct-acting and reversible p2y12 inhibitor |
| 02/12/2009 | US20090043379 Drug delivery systems for the prevention and treatment of vascular diseases |
| 02/12/2009 | US20090042948 Physiologically acceptable salts of 3--1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester |
| 02/12/2009 | US20090042946 Method and kit for controlling bleeding |
| 02/12/2009 | US20090042930 Pharmaceutical compositions containing clopidogrel bisulfate |
| 02/12/2009 | US20090042916 [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related thereto |
| 02/12/2009 | US20090042885 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 02/12/2009 | US20090042877 such as ethyl 6-oxo-7-phenyl-3-(pyridin-3-ylamino)-6,7-dihydrothieno [2,3-b]pyridine-2-carboxylate, potent and selective inhibitors of p38 MAP kinase and are of use in the prophylaxis and treatment of immune or inflammatory disorders |
| 02/12/2009 | US20090042869 SIGNAL-DEPENDENT SPLICING OF TISSUE FACTOR PRE-mRNA IN PLATELET CELLS |
| 02/12/2009 | US20090042866 Tetrahydrocarbazoles as Active Agents for Inhibiting VEGF Production by Translational Control |
| 02/12/2009 | US20090042800 Assay |
| 02/12/2009 | US20090042787 Proteolytically cleavable fusion proteins with high molar specific activity |
| 02/12/2009 | US20090042199 Nucleotide sequences coding lymphocyte adhesion protein for use in treatment of autoimmunity, inflammation and infection |
| 02/12/2009 | US20090041869 Method of reducing insect resistant pests in transgenic crops |
| 02/12/2009 | US20090041858 Haemostatic Compositions Thickened by Polymers Containing Nitrogen Moieties |
| 02/12/2009 | US20090041850 Process for preparation of swellable and degradable microspheres |
| 02/12/2009 | US20090041766 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 02/12/2009 | US20090041744 Dimeric and Multimeric FVIIa Compounds |
| 02/12/2009 | US20090041737 Cold storage of modified platelets |
| 02/12/2009 | US20090041731 Treatment for Diabetes |
| 02/12/2009 | US20090041714 Polymer-factor VIII moiety conjugates |
| 02/11/2009 | EP2021028A2 Methods and compositions for modulation of blood-neural barrier |
| 02/11/2009 | EP1370561B1 Tetrahydro-pyrazino[1,2-a]indoles for the treatment of central nervous disorders |
| 02/11/2009 | EP1309334B1 Combination therapy using reovirus and anti-antireovirus antibodies for the treatment of ras-mediated proliferative disorders |
| 02/11/2009 | CN101365477A Pharmaceutical composition for treating haemorrhagic shock and its controlled-release capsules or tables |
| 02/11/2009 | CN101365463A Antacid |
| 02/11/2009 | CN101365453A Dipyridamole extended-release formulations and process for preparing same |
| 02/11/2009 | CN101363029A Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex DNA |
| 02/11/2009 | CN101362803A Fusion proteins of tick anticoagulant peptide and staphylococcus aureus superantigen-like protein, preparation and application thereof |
| 02/11/2009 | CN101362797A Thrombopoietin mimic peptide, preparation and application thereof |
| 02/11/2009 | CN101362746A Separation method of argatroban single stereoisomers and polymorph |
| 02/11/2009 | CN101361980A Heparin phospholipid composite suitable for non-injection administration and preparation method thereof |
| 02/11/2009 | CN101361967A Y2/Y4 selective receptor agonists for therapeutic interventions |
| 02/11/2009 | CN101361858A Medicine for treating aplastic anemia |
| 02/11/2009 | CN101361851A Anti-coccidian, hemostasia and blood regeneration, antibiosis and anti-inflammation traditional Chinese medicine combination and preparation method thereof |
| 02/11/2009 | CN101361839A Quality control detection method of Xuefu Zhuyu oral liquid |
| 02/11/2009 | CN101361717A Batroxobin freeze-dry powder injection and preparation method thereof |
| 02/11/2009 | CN100460414C Stable vitamin B6 derivative |
| 02/10/2009 | US7488739 platelet aggregation inhibitors; anti-platelet agent with a high safety profile with a smaller adverse bleeding effect; P2Y12 inhibitor; (2S)-2-({[7-(cyclohexylamino)-1-cyclopentyl-6-fluoro-4-oxo-1,4-dihydroquinolin-3-yl]carbonyl}amino)butanedioic acid |
| 02/10/2009 | US7488734 Anticancer agents; hormone replacement therapy; contraceptives |
| 02/10/2009 | US7488494 Competitive binding to estrogen; prevent mnopause syndrome ; anxiolytic agents; antidepressants; benign prostatic hyperplasia; anticancer agents; inflammatory bowel disorders; antiarthritic agents |
| 02/10/2009 | CA2389709C Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 02/05/2009 | WO2009018405A1 Integrated photoactive agents and uses thereof |
| 02/05/2009 | WO2009017655A2 Methods and compositions for stimulating the proliferation or differentiation of stem cells with substance p or an analog thereof |
| 02/05/2009 | WO2009017161A1 Inhibitory agent for inflammatory cytokine |
| 02/05/2009 | WO2009017098A1 Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof |
| 02/05/2009 | WO2009016812A1 Prophylactic and/or therapeutic agent for anemia comprising 2-phenylquinoline-4-carboxylic acid derivative as active ingredient |
| 02/05/2009 | WO2009007661A3 Use of a chromatography substrate for reducing the amount of adamts13 in a solution derived from plasma |
| 02/05/2009 | WO2008137787A3 Combination therapy with a compound acting as a platelet adp receptor inhibitor |
| 02/05/2009 | US20090036517 Anti-angiogenic compositions and methods of use |
| 02/05/2009 | US20090036504 2-Aminoethoxyacetic Acid Derivatives and Their Use |
| 02/05/2009 | US20090036442 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/05/2009 | US20090036438 Five-membered heterocycles useful as serine protease inhibitors |
| 02/05/2009 | US20090036412 Methods and Compositions for Inhibition of Angiogenesis |
| 02/05/2009 | US20090036406 Injection |
| 02/05/2009 | US20090036366 Inhibitors of human plasmin derived from the kunitz domains |
| 02/05/2009 | US20090036365 Inhibitors of human plasmin derived from the kunitz domains |
| 02/05/2009 | US20090036361 Use of Blood Coagulation Factor XIII for Treating Hemophilia A |
| 02/05/2009 | US20090036360 Medicament containing activated antithrombin iii |
| 02/05/2009 | US20090036358 Methods of preparing pharmaceutical compositions for treatment of factor Vlll associated disorders and methods of use |
| 02/05/2009 | US20090036352 Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin and derivatives thereof |
| 02/05/2009 | US20090035386 Conditioning of a patient's blood by gases |
| 02/05/2009 | US20090035373 Pharmaceutical composition for contraception and blood pressure regulation, kit for contraception containing same and method of production of same |
| 02/05/2009 | US20090035297 Methods for treating diabetes |
| 02/05/2009 | CA2695197A1 Integrated photoactive agents and uses thereof |
| 02/05/2009 | CA2694696A1 Methods and compositions for stimulating the proliferation or differentiation of stem cells with substance p or an analog thereof |
| 02/05/2009 | CA2694567A1 Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof |
| 02/04/2009 | EP2020411A1 Spiro tetracyclic compound |
| 02/04/2009 | EP2020239A1 Use of IL-174 agonists for treating infectious diseases |
| 02/04/2009 | CN101360824A Lipopolysaccharide- or lipid A-binder, and novel peptide |
| 02/04/2009 | CN101358184A Hemocoagulase agkistrodon |
| 02/04/2009 | CN101357914A Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 02/04/2009 | CN101357211A Traditional Chinese medicine navel paste for treating hepatocirrhosis endotoxemia and preparation method thereof |
| 02/04/2009 | CN101357198A Traditional Chinese medicine for treating cerebral thrombus |
| 02/04/2009 | CN101357178A Traditional Chinese medicine composition for treating the cerebrovascular disease |
| 02/04/2009 | CN101357154A Chinese herbal medicine composition with bacteriostasis, anti-inflammation hemostasia effect |
| 02/04/2009 | CN101357144A Selaginella uncinata extraction, its preparation method and application |
| 02/04/2009 | CN101357142A Use of Clostridium butyricum in preparing medicine composition for preventing and treating cerebrovascular disease |
| 02/04/2009 | CN101357138A Natural zeolite emergence haemostatic and preparation method thereof |
| 02/04/2009 | CN100457897C Preparation process of and use of thrombus dissolving enzyme |
| 02/04/2009 | CN100457753C N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 02/04/2009 | CN100457173C Medicine for treating disease due to kidney yang vacuity |
| 02/04/2009 | CN100457165C Chinese medicine for treating Hematuria and its preparing method and use |
| 02/04/2009 | CN100457162C Oral medicine for treating cerebral blood-supply deficiency giddiness and cava infarction and hyperthrombinemia |
| 02/04/2009 | CN100457154C Compound longxuejie preparation, preparing technique and application |
| 02/04/2009 | CN100457146C Capsule with diuresis promoting function containing amber and toad |
| 02/04/2009 | CN100457138C Process for preparing fresh motherwort powder |
| 02/04/2009 | CN100457136C Chinese medicine for preventing from subcutaneous hemorrhage after pulling out needle |
| 02/04/2009 | CN100457115C Blood flow modifier and thrombus prophylactic agent or medicines |
| 02/04/2009 | CN100457088C Pharmaceutical composition comprising lipids comprising polar and nonpolar moiety parts |
| 02/03/2009 | US7485730 Pharmaceutical compounds |